Research Type: Academic Literature
Academic literature is reviewed by peer experts in a scientific field before it is approved for publication. The acceptance of our opinions and research after this vetting process indicates its relevance to current policies and other important drug and device issues.
-
Prevalence of Off-Label Use and Spending Among Patent-Protected Chemotherapies
-
Pharmaceutical Products and Their Value
-
Understanding the Rewards of Successful Drug Development: Thinking Inside the Box
-
Medicare Negotiation: A “Too Little” or “Too Late” Framework for Drug Selection
-
Abandon Biosimilars as Biologics are Natural Monopolies
-
List Price, Net Price, and the Rebate Caught in the Middle
-
Expansion of the Medicare 340B Payment Program
-
The “Netflix Model” of Financing Hepatitis C Treatment
-
Cardiovascular Drugs Not Price Aligned with Value in US
-
Perspective on National Coverage Analysis of CAR-T Therapies